FDA Import Refusal 799-2936888-0/10003/1 — Softgel Healthcare Private Limited
The FDA refused shipment 799-2936888-0/10003/1 from Softgel Healthcare Private Limited (India) on Mar 5, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Mar 5, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75